Sandy Macrae
President, CEO and Director at Sangamo Therapeutics, Inc (SGMO)
Sandy Macrae has filed 22 insider reports with the SEC since January 2021, as president and CEO and Director at Sangamo Therapeutics, Inc (SGMO). The latest filing, on May 27, 2026, reports shares withheld for taxes or exercise price at Sangamo Therapeutics, Inc (SGMO).
- Filings
- 22
- Companies
- 1
- Bought on market
- None
- Sold on market
- None
Companies where Sandy Macrae is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| President, CEO and Director | 1,895,043 | May 27, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- May 25, 2026SGMOPRESIDENT, CEO AND DIRECTOR Macrae Sandy covered exercise/tax liability with 12,613 shares, decreasing direct ownership by 0.66% to 1,895,043 units (for tax liability)Form 4Shares withheld for taxes or exercise price
- Apr 1, 2026SGMOSEC Form 4 filed by Macrae SandyForm 4Grant or award
- Jan 22, 2026SGMOPRESIDENT, CEO AND DIRECTOR Macrae Sandy covered exercise/tax liability with 102,950 shares, decreasing direct ownership by 5% to 1,946,584 unitsForm 4Shares withheld for taxes or exercise price
- Nov 24, 2025SGMOPRESIDENT, CEO AND DIRECTOR Macrae Sandy covered exercise/tax liability with 7,488 shares, decreasing direct ownership by 0.36% to 2,049,534 unitsForm 4Shares withheld for taxes or exercise price
- Oct 22, 2025SGMOPRESIDENT, CEO AND DIRECTOR Macrae Sandy covered exercise/tax liability with 126,950 shares, decreasing direct ownership by 6% to 2,057,022 unitsForm 4Shares withheld for taxes or exercise price
- Aug 24, 2025SGMOPRESIDENT, CEO AND DIRECTOR Macrae Sandy covered exercise/tax liability with 7,488 shares, decreasing direct ownership by 0.34% to 2,183,972 unitsForm 4Shares withheld for taxes or exercise price
- Jul 22, 2025SGMOPRESIDENT, CEO AND DIRECTOR Macrae Sandy covered exercise/tax liability with 126,950 shares, decreasing direct ownership by 5% to 2,191,460 unitsForm 4Shares withheld for taxes or exercise price
- May 24, 2025SGMOPRESIDENT, CEO AND DIRECTOR Macrae Sandy covered exercise/tax liability with 7,488 shares, decreasing direct ownership by 0.32% to 2,318,410 unitsForm 4Shares withheld for taxes or exercise price
- Apr 22, 2025SGMOPRESIDENT, CEO AND DIRECTOR Macrae Sandy covered exercise/tax liability with 126,950 shares, decreasing direct ownership by 5% to 2,325,898 unitsForm 4Shares withheld for taxes or exercise price
- Feb 25, 2025SGMOPRESIDENT, CEO AND DIRECTOR Macrae Sandy covered exercise/tax liability with 18,151 shares and was granted 375,000 shares, increasing direct ownership by 17% to 2,452,848 unitsForm 4Grant or awardShares withheld for taxes or exercise price
- Jan 22, 2025SGMOPRESIDENT, CEO AND DIRECTOR Macrae Sandy covered exercise/tax liability with 412,584 shares, decreasing direct ownership by 16% to 2,095,999 unitsForm 4Shares withheld for taxes or exercise price
- Nov 25, 2024SGMOPRESIDENT, CEO AND DIRECTOR Macrae Sandy covered exercise/tax liability with 18,115 shares, decreasing direct ownership by 0.72% to 2,508,583 unitsForm 4Shares withheld for taxes or exercise price
- Aug 25, 2024SGMOPRESIDENT, CEO AND DIRECTOR Macrae Sandy covered exercise/tax liability with 12,753 shares, decreasing direct ownership by 0.50% to 2,526,698 unitsForm 4Shares withheld for taxes or exercise price
- May 25, 2024SGMOMacrae Sandy covered exercise/tax liability with 12,753 shares, decreasing direct ownership by 0.50% to 2,539,451 unitsForm 4Shares withheld for taxes or exercise price
- Feb 25, 2024SGMOMacrae Sandy covered exercise/tax liability with 40,272 shares, decreasing direct ownership by 2% to 2,552,204 unitsForm 4Shares withheld for taxes or exercise price
- Jan 22, 2024SGMOMacrae Sandy was granted 2,000,000 shares, increasing direct ownership by 338% to 2,592,476 unitsForm 4Grant or award
- Nov 25, 2023SGMOMacrae Sandy covered exercise/tax liability with 10,411 shares, decreasing direct ownership by 2% to 592,476 unitsForm 4Shares withheld for taxes or exercise price
- Aug 25, 2023SGMOSEC Form 4: Macrae Sandy covered exercise/tax liability with 10,411 shares, decreasing direct ownership by 2% to 602,887 unitsForm 4Shares withheld for taxes or exercise price
- May 25, 2023SGMOSEC Form 4 filed by Macrae SandyForm 4Shares withheld for taxes or exercise price
- Feb 25, 2022SGMOSEC Form 4: Macrae Sandy was granted 224,000 shares and covered exercise/tax liability with 49,890 shares, increasing direct ownership by 50% to 521,176 units (tax liability)Form 4Grant or awardShares withheld for taxes or exercise price
- Feb 25, 2021SGMOSEC Form 4: Sandy Macrae disposed of $395,130 worth of Common Stock (35,311 units at $11.19) and was granted 138,375 units of Common Stock, increasing ownership by 42% to 347,066 unitsForm 4Grant or awardShares withheld for taxes or exercise price
- Jan 24, 2021SGMOSEC Form 4: Sandy Macrae disposed of $59,456 worth of Common Stock (3,977 units at $14.95), decreasing ownership by 2% to 244,002 unitsForm 4Shares withheld for taxes or exercise price
Compare Sandy Macrae with
- Sandy Macrae vs Nikunj Jain1 shared
- Sandy Macrae vs Gregory D Davis1 shared
- Sandy Macrae vs Nathalie Dubois-Stringfellow1 shared
- Sandy Macrae vs Scott B. Willoughby1 shared
- Sandy Macrae vs Prathyusha Duraibabu1 shared
- Sandy Macrae vs Karen L. Smith1 shared
Other insiders at the same companies
- Gregory D DavisSGMO
- Nikunj JainSGMO
- Nathalie Dubois-StringfellowSGMO
- Scott B. WilloughbySGMO
- Prathyusha DuraibabuSGMO
- Robert CareySGMO
- Karen L. SmithSGMO
- H Stewart ParkerSGMO
- Kenneth J. HillanSGMO
- John MarkelsSGMO
- James R MeyersSGMO
- Margaret A HornSGMO
- Courtney BeersSGMO
Questions about Sandy Macrae
- What is Sandy Macrae's role at Sangamo Therapeutics, Inc?
- Sandy Macrae reports to the SEC as president and CEO and Director at Sangamo Therapeutics, Inc (SGMO), according to the latest filing on May 27, 2026.
- How many shares does Sandy Macrae own?
- After the latest filing that states it, Sandy Macrae directly owned 1,895,043 shares of Sangamo Therapeutics, Inc (SGMO). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Sandy Macrae bought or sold stock recently?
- No open-market purchases or sales by Sandy Macrae are on file. The filings report shares withheld for taxes or exercise price and grant or award.
- How do I get alerts when Sandy Macrae files?
- Follow Sandy Macrae on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Sandy Macrae (SEC CIK 0001675687). Totals count each trade once, skipping amendments whose original is on file, from Jan 27, 2021 on. View on SEC EDGAR · Get this as JSON